Clinical Use of Micronized Purified Flavonoid Fraction for Treatment of Symptoms after Hemorrhoidectomy: Results of a Randomized, Controlled, Clinical Trial

Diseases of the Colon and Rectum

Volumn 47, Issue 5, 2004, Pages 704-710

  La Torre, F ^a,b   Nicolai, A P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Flavonoids; Hemorrhoidectomy; Hemorrhoids; Hesperidin; Micronized flavonoid fraction; Micronized purified flavonoid fraction

Indexed keywords

ALVENOR; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ARDIUM; ARVENUM; CAPIVEN; DAFLON; DETRALEX; ELATEC; FLAVONOID; FLEBOTROPIN; HESPERIDIN; KETOROLAC; METRONIDAZOLE; MICRONIZED PURIFIED FLAVONOID FRACTION; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; VARITON; VENITOL;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMORRHOID; HEMORRHOIDECTOMY; HUMAN; MALE; PAIN; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME; WOUND HEALING;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; FEMALE; FLAVONOIDS; HEMORRHOIDS; HUMANS; KETOROLAC TROMETHAMINE; MALE; METRONIDAZOLE; MIDDLE AGED; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PRURITUS ANI; SPASM;

EID: 2342460336     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-003-0119-1     Document Type: Article

References (39)

1. Milligan ET, Morgan CN, Jones LE, Officer R. Surgical anatomy of the anal canal and operative treatments of haemorrhoids. Lancet 1937;2:1119-24
2. Brisinda G. How to treat haemorrhoids. BMJ 2000;321: 582-3
3. MacKay D. Hemorrhoids and varicose veins: a review of treatment options. Altern Med Rev 2001;6:126-40
4. MacRae HM, McLeod RS. Comparison of hemorrhoidal treatments: a meta-analysis. Can J Surg 1997;40:14-7
5. La Torre F, Nicastro A, Masoni L, Clarioni A, Montori A. Pain after haemorrhoidectomy. Coloproctology 1992;2: 107-9
6. Eu KW, Seow-Choen F, Goh HS. Comparison of emergency and elective haemorrhoidectomy. Br J Surg 1994; 81:308-10
7. Brisinda G, Civello IM, Maria G. Haemorrhoidectomy: painful choice. Lancet 2000;355:2253
8. Andrews BT, Layer GT, Jackson BT, Nicholls RJ. Randomized trial comparing diathermy hemorrhoidectomy with the scissor dissection Milligan-Morgan operation. Dis Colon Rectum 1993;36:580-3
9. Sielzneff L, Salle L, Lécuyer J, Brunet C, Sarles JC, Sastre B. Early postoperative morbidity after hemorrhoidectomy using Milligan-Morgan technique. A retrospective studies of 1134 cases. J Chir (Paris) 1997;134:243-7
10. Abramovitz L, Godeberge P, Staumont G, Soudan D. Clinical practice guidelines for the treatment of hemorrhoidal disease. Gastroenterol Clin Biol 2001;25:690-4
11. Bleday R, Pena JP, Rothenberger DA, Goldberg SM, Buls JG. Symptomatic hemorrhoids: current incidence and complications of operative therapy. Dis Colon Rectum 1992;35:477-81
12. Johnson CD, Budd J, Ward AJ. Laxatives after haemorrhoidectomy. Dis Colon Rectum 1987;30:780-1
13. Denis J, Dubois N, Ganansia R, du Puy-Montbrun T, Lemarchand N. Hemorrhoidectomy: Hospital Leopold-Bellan procedure. Int Surg 1989;74:152-3
14. Boccasanta P, Venturi M, Orio A, et al. Circular hemorrhoidectomy in advanced hemorrhoidal disease. Hepatogastroenterology 1998;45:969-72
15. Ho YH, Foo CL, Seow-Choen F, Goh HS. Prospective randomized controlled trial of a micronized flavonoid fraction to reduce bleeding after haemorrhoidectomy. Br J Surg 1995;82:1034-5
16. Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of MPFF in the treatment of acute haemorrhoids. Angiology 1994;445:566-73
17. Cospite M, Cospite V. Treatment of haemorrhoids with Daflon 500 mg. Phlebology 1992;7:53-6
18. Godeberge P. MPFF is significantly more effective than placebo in the treatment of haemorrhoids. Phlebology 1992;7:61-3
19. Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding due to acute internal haemorrhoids. BrJ Surg 2000;87:868-72
20. Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal haemorrhoids of pregnancy. Int Gynaecol Obstet 1997;57:145-51
21. Johanson JF. Evidence-based approach to the treatment of hemorrhoidal disease. Evidence-Based Gastroenterology 2002;3:26-31
22. Garner RC, Leong D, Gregory S, et al. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized diosmin tablets after oral administration to healthy volunteers analyzed by Accelerator Mass Spectrometry. J Pharm Sci 2001;91:32-40
23. Bouskela E, Cyrino FZ, Lerond L. Micronization enhances the protective effect of purified flavonoid fraction on postischemic microvascular injury in the hamster cheek pouch. Int Angiol 2001;20:19
24. Bakri F. Interaction d'une fraction flavonoidique avec la noradrénaline sur la veine saphène humaine isolée. Phlebologie 1989;2:669-71
25. Ibegbuna V, Nicolaides AN, Sowade O, et al. Venous elasticity after treatment with MPFF. Angiology 1997;48: 45-9
26. Duhault J, Pillion G. Mecanisme d'action de Daflon 500 mg sur le tonus veineux noradrénergique. Arteres Veines 1992;11:217-8
27. Amiel M, Barbe R. Etude de l'activité pharmacodynamique de Daflon 500 mg. Ann Cardio Angeiol 1998;47: 185-8
28. Bouskela E, Donyo KA, Verbeuren TJ. Effects of Daflon 500 mg on increased microvascular permeability in normal hamsters. Int J Microcirc 1995;15:22-6
29. Galley P, Thiollet M. A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol 1993;12:69-72
30. Cotonat J. Activité lymphagogue du Daflon 500 mg in vivo chez les chiens. Concilia Med 1988;7:17-21
31. McHale NG, Hollywood MA. Control of lymphatic pumping: interest of Daflon 500 mg. Phlebology 1994; 9:23-5
32. Shoab SS, Porter JB, Scurr JH, Coleridge-Smith PD. Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - a prospective study. Eur J Vasc Endovasc Surg 1999;17: 313-8
33. Nolte D, Pickelman S, Schütze E, et al. Effects of Daflon 500 mg on postischemic macromolecular leak syndrome in striated skin muscle of the hamster. Int J Microcirc 1997;17:6-9
34. Korthuis RJ, Gute DC. Postichemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: cellular mechanisms and effect of Daflon 500 mg. Int J Microcirc 1997;17:11-7
35. Takase S, Delano FA, Lerond L, Bergan JJ, Schmid-Schönbein GW. Inflammation in chronic venous insufficiency: is the problem insurmountable? J Vasc Res 1999;36:3-10
36. Meyer OC. Safety of use of Daflon 500 mg confirmed by acquired experience and new research. Angiology 1997;45:579-84
37. Peng BC, Jayne DG, Ho YH. Randomized trial of rubber band ligation vs. stapled hemorrhoidectomy for prolapsed piles. Dis Colon Rectum 2003;46:291-7
38. Carapeti EA, Kamm MA, McDonald PJ, Phillips RK. Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy. Lancet 1998;351:169-72
39. Ho YH, Tan M, Seow-Choen F. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial. Dis Colon Rectum 2000;43:66-9